KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Tax Assets (2016 - 2018)

Idexx Laboratories (IDXX) has 9 years of Current Deferred Tax Assets data on record, last reported at $23.5 million in Q4 2017.

  • For Q4 2017, Current Deferred Tax Assets rose 30.05% year-over-year to $23.5 million; the TTM value through Dec 2017 reached $23.5 million, up 30.05%, while the annual FY2017 figure was $23.5 million, 30.05% up from the prior year.
  • Current Deferred Tax Assets reached $23.5 million in Q4 2017 per IDXX's latest filing, up from $22.2 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $39.8 million in Q4 2015 and bottomed at $14.2 million in Q2 2015.
  • Average Current Deferred Tax Assets over 5 years is $26.9 million, with a median of $26.4 million recorded in 2013.
  • Peak YoY movement for Current Deferred Tax Assets: crashed 57.89% in 2015, then soared 30.05% in 2017.
  • A 5-year view of Current Deferred Tax Assets shows it stood at $33.2 million in 2013, then increased by 13.43% to $37.7 million in 2014, then grew by 5.68% to $39.8 million in 2015, then plummeted by 54.59% to $18.1 million in 2016, then skyrocketed by 30.05% to $23.5 million in 2017.
  • Per Business Quant database, its latest 3 readings for Current Deferred Tax Assets were $23.5 million in Q4 2017, $22.2 million in Q3 2017, and $19.4 million in Q1 2017.